Skip to main content area

Roadshow

ACTOnco®+ analyzes

ACTOnco®+ analyzes >400 genes and 13 fusion genes to assist physicians identify the most suitable therapies.

ACTOnco®+ analyzes >400 genes and 13 fusion genes to assist physicians identify the most suitable therapies. Treatment evaluations include targeted therapy, immunotherapy, hormone therapy, and chemotherapy.

poster of  ACTOnco+ analyzes

ACT Genomics

<p>ACT Genomics is an award-winning cancer solution provider founded in 2014 by a small group of scientists from academia. With our name, ACT Genomics, reflecting our passion to &ldquo;turn genomics into action&rdquo;, we set out to apply academic theories in clinical practice and truly make personalized cancer care accessible to all.</p> <p>&nbsp;</p> <p>Over the years, our practical experience has helped academic research make remarkable progress, which has in turn enhanced our cancer solutions with high efficiency and accuracy. As a pioneer in Taiwan and the wider Asian region, we are committed to empowering cancer patients with advanced genomic treatments and continuing to make strides forward in precision medicine.</p>

※All the following are required
field spacing
Back to top